Form D · Other Technology

Axon Therapies Inc.

New York, NY · CIK 0001671158

Offering snapshot reported Feb 7, 2019 · SEC filing

Reported sold
$7.5M
Offering amount: $15M
Investors reported
10
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jan 23, 2019
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$37.5M$75MFeb 7, 2019: $74,999,993.00Feb 7, 2019Feb 7, 2019: $7,499,994.00Feb 7, 2019

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$74,999,993 → $7,499,994

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Feb 7, 2019Initial$74,999,993No comparison10SEC filing
Feb 7, 2019Amendment$7,499,994-$67,499,999vs Feb 7, 201910SEC filing
Jun 28, 2017Initial$1,299,999No comparison7SEC filing
Apr 19, 2016Initial$2,000,000No comparison1SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-332379

Source: Form D, filed Feb 7, 2019. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Mitchell S. Bloom Executive
Imran Eba Director
Andrew El Bardissi Director
Mark Gelfand Director, Executive
Steven Hochberg Director
Paul La Violette Director
Howard R. Levin Director, Executive

Issuer details

Industry: Other Technology (See others in industry)

Address:
C/O Coridea, Llc 315 West 36 Th Street
New York, NY, 10018